Sign in
4

Changes in Ownership

MAIA Biotechnology, Inc. Filed Acc 0001127602-25-004350

Options or other derivatives

  • Chief Scientific Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gryaznov Sergei · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-10 Grant or award : show line 1 in the form Stock Options +200,000 200,000 D
Loading xslF345X05/form4.xml…